Clinical trial
Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic…
NCT00364468 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00364468 |
|---|---|
| Title | Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients |
| Official title | A Randomized Dose Finding Study of KRN125 (Pegfilgrastim) for the Treatment of Chemotherapy - Induced Neutropenia in Malignant Lymphoma |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neutropenia |
| Intervention type | Drug |
| Interventions | pegfilgrastim |
| Enrollment | 107 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Aug 15, 2006 |
| Last update posted | Mar 3, 2017 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: